Regulation of P2X Purinergic Receptor Signaling by Cholesterol

被引:39
|
作者
Murrell-Lagnado, Ruth D. [1 ]
机构
[1] Univ Sussex, Sussex Neurosci, Sch Life Sci, Brighton, E Sussex, England
来源
关键词
ALVEOLAR EPITHELIAL-CELLS; LIPID RAFTS; CALMODULIN-BINDING; HUMAN-LYMPHOCYTES; ION-CHANNEL; CAVEOLIN-1; EXPRESSION; PALMITOYLATION; MACROPHAGES; ACTIVATION;
D O I
10.1016/bs.ctm.2017.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P2X receptors are cation-selective channels that are activated by the binding of extracellular ATP. They have a high permeability to Ca2+, Na+, and K+ and are expressed widely throughout the nervous, immune, cardiovascular, skeletal, gastrointestinal, respiratory, and endocrine systems. Seven mammalian subtypes of P2X receptor subunits have been identified, P2X1-7, and those that function as homotrimeric receptors (P2X1, 2, 3, 4, and 7) are targeted to lipid rafts, although they show limited resistance to solubilization by Triton X-100. Recent crystal structures of P2X3 and P2X4 receptors have provided considerable high-resolution information about the architecture of this family of receptors and yet the molecular details of how they are regulated by cholesterol are unknown. Currents mediated by the P2X1-4 receptors are either inhibited or relatively insensitive to cholesterol depletion, but there is no clear evidence to support the direct binding of cholesterol to these receptors. In contrast, the activity of the low-affinity, proinflammatory P2X7 receptor is potentiated by cholesterol depletion and regions within the proximal C-terminus play an important role in coupling changes in cholesterol to the gating of the pore. Based upon our understanding of the lipid signaling events that are triggered downstream of P2X7 receptor activation, a change in the levels of cholesterol may contribute to the sensitization of receptor currents and the dilation of the pore that occurs following prolonged, high-level stimulation. This chapter focuses on the regulation of P2X7 receptor signaling by cholesterol and our current understanding of the mechanisms that underlie this.
引用
收藏
页码:211 / 232
页数:22
相关论文
共 50 条
  • [1] SIGNALING BY PURINERGIC P2X RECEPTOR CHANNELS
    Stojilkovic, Stanko S.
    Yan, Zonghe
    Zemkova, Hana
    Li, Shuo
    Tomic, Melanija
    [J]. NEUROPEPTIDES, 2009, 43 (02) : 162 - 163
  • [2] Activation and Regulation of Purinergic P2X Receptor Channels
    Coddou, Claudio
    Yan, Zonghe
    Obsil, Tomas
    Pablo Huidobro-Toro, J.
    Stojilkovic, Stanko S.
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (03) : 641 - 683
  • [3] Signaling at Purinergic P2X Receptors
    Surprenant, Annmarie
    North, R. Alan
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2009, 71 : 333 - 359
  • [4] P2X receptor-mediated ATP purinergic signaling in health and disease
    Jiang, Lin-Hua
    [J]. CELL HEALTH AND CYTOSKELETON, 2012, 4 : 83 - 101
  • [5] Molecular dissection of purinergic P2X receptor channels
    Stojilkovic, SS
    Tomic, M
    Mu-Lan, HE
    Yan, ZH
    Koshimizu, TA
    Zemkova, H
    [J]. BIOPHYSICS FROM MOLECULES TO BRAIN: IN MEMORY OF RADOSLAV K. ANDJUS, 2005, 1048 : 116 - 130
  • [6] lonotropic P2X ATP Receptor Channels Mediate Purinergic Signaling in Mouse Odontoblasts
    Shiozaki, Yuta
    Sato, Masaki
    Kimura, Maki
    Sato, Toru
    Tazaki, Masakazu
    Shibukawa, Yoshiyuki
    [J]. FRONTIERS IN PHYSIOLOGY, 2017, 8
  • [7] Epithelial P2X purinergic receptor channel expression and function
    Taylor, AL
    Schwiebert, LM
    Smith, JJ
    King, C
    Jones, JR
    Sorscher, EJ
    Schwiebert, EM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (07): : 875 - 884
  • [8] P2X purinergic receptor responsiveness in exercising skeletal muscle
    Buckwalter, JB
    Hamann, JJ
    Clifford, PS
    [J]. FASEB JOURNAL, 2003, 17 (04): : A21 - A21
  • [9] P2X (purinergic) receptor distributions in rat blood vessels
    Hansen, MA
    Dutton, JL
    Balcar, VJ
    Barden, JA
    Bennett, MR
    [J]. JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1999, 75 (2-3): : 147 - 155
  • [10] P2X purinergic receptor ligands: recently patented compounds
    Gunosewoyo, Hendra
    Kassiou, Michael
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (05) : 625 - 646